[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Sidekick Health\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100592132","digital-patient-support-program-for-self-efficacy-and-medication-adherence-in-women-on-adjuvant-endocrine-treatment-for-breast-cancer-100592132",false,"NCT06989450","Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer","Digital Patient Support Program for Self-Efficacy and Medication Adherence Amongst Women on Adjuvant Endocrine Treatment for Breast Cancer: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Adult patient (18 years or older) diagnosed with breast cancer of stage I, II or III from 1st September 2023 or later\n* Have been prescribed adjuvant endocrine therapy for breast cancer.\n* Understands written and spoken Icelandic or English.\n* Owns a smart-phone compatible with the Sidekick app and capable to use it\n* Willing to download the Sidekick app on the smart-phone and to comply with the study measures and visits according to the protocol.\n* Capable of providing informed consent for participating in the study.\n\nExclusion Criteria:\n\n* Having other concurrent conditions that in the opinion of the oncologist may compromise patient safety or study objectives.\n* Concurrent participation in another clinical study in which the study treatment may confound the evaluation of the investigational program.\n* Metastatic breast cancer (stage IV)\n* Previous experience with Sidekick breast cancer program","FEMALE","18 Years",{"count":19,"type":20},140,"ESTIMATED","INTERVENTIONAL",[23],"NA","This is a randomized, controlled study to assess the effect of Sidekick Health's digital program on self-efficacy and medication adherence in breast cancer patients prescribed adjuvant anti-hormonal treatment. Participants will be treated with the digital program in addition to standard of care (SoC), or SoC only.",[26,27],"Breast Cancer","Cancer",[27,26,29,30,31,32,33],"Medication adherence","self-efficacy","lifestyle change","endocrine treatment","digital health application","RECRUITING","2025-05-16",{"date":37,"type":38},"2025-05-25","ACTUAL",{"date":40,"type":20},"2025-05-31",{"date":42,"type":20},"2026-12-30",{"name":44,"class":45},"Sidekick Health","INDUSTRY",""]